-
1
-
-
33645957381
-
Selenium speciation analysis using inductively coupled plasma-mass spectrometry
-
16551466 10.1016/j.chroma.2006.02.063
-
C B'Hymer JA Caruso 2006 Selenium speciation analysis using inductively coupled plasma-mass spectrometry J Chromatogr A 1114 1 20 16551466 10.1016/j.chroma.2006.02.063
-
(2006)
J Chromatogr A
, vol.1114
, pp. 1-20
-
-
B'Hymer, C.1
Caruso, J.A.2
-
2
-
-
69449107156
-
NF-kappaB activation, dependent on acetylation/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells
-
19671685 10.1158/1541-7786.MCR-08-0548 1:CAS:528:DC%2BD1MXhtVWrsL%2FE
-
P Bendinelli E Matteucci P Maroni MA Desiderio 2009 NF-kappaB activation, dependent on acetylation/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells Mol Cancer Res 7 1328 1341 19671685 10.1158/1541-7786.MCR-08-0548 1:CAS:528:DC%2BD1MXhtVWrsL%2FE
-
(2009)
Mol Cancer Res
, vol.7
, pp. 1328-1341
-
-
Bendinelli, P.1
Matteucci, E.2
Maroni, P.3
Desiderio, M.A.4
-
3
-
-
52449104467
-
Tumor vascular maturation and improved drug delivery induced by methylselenocysteine leads to therapeutic synergy with anticancer drugs
-
18559614 10.1158/1078-0432.CCR-08-0212 1:CAS:528:DC%2BD1cXntlWrtbo%3D
-
A Bhattacharya M Seshadri SD Oven K Toth MM Vaughan YM Rustum 2008 Tumor vascular maturation and improved drug delivery induced by methylselenocysteine leads to therapeutic synergy with anticancer drugs Clin Cancer Res 14 3926 3932 18559614 10.1158/1078-0432.CCR-08-0212 1:CAS:528:DC%2BD1cXntlWrtbo%3D
-
(2008)
Clin Cancer Res
, vol.14
, pp. 3926-3932
-
-
Bhattacharya, A.1
Seshadri, M.2
Oven, S.D.3
Toth, K.4
Vaughan, M.M.5
Rustum, Y.M.6
-
4
-
-
1842478439
-
Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts
-
15073137 10.1158/1078-0432.CCR-03-0268 1:CAS:528:DC%2BD2cXivFSqsbc%3D
-
S Cao FA Durrani YM Rustum 2004 Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts Clin Cancer Res 10 2561 2569 15073137 10.1158/1078-0432.CCR-03- 0268 1:CAS:528:DC%2BD2cXivFSqsbc%3D
-
(2004)
Clin Cancer Res
, vol.10
, pp. 2561-2569
-
-
Cao, S.1
Durrani, F.A.2
Rustum, Y.M.3
-
5
-
-
80054690818
-
Cysteine S-conjugate beta-lyases: Important roles in the metabolism of naturally occurring sulfur and selenium-containing compounds, xenobiotics and anticancer agents
-
Cooper AJ, Krasnikov BF, Niatsetskaya ZV, Pinto JT, Callery PS, Villar MT, Artigues A, Bruschi SA (2010) Cysteine S-conjugate beta-lyases: important roles in the metabolism of naturally occurring sulfur and selenium-containing compounds, xenobiotics and anticancer agents. Amino Acids
-
(2010)
Amino Acids
-
-
Cooper, A.J.1
Krasnikov, B.F.2
Niatsetskaya, Z.V.3
Pinto, J.T.4
Callery, P.S.5
Villar, M.T.6
Artigues, A.7
Bruschi, S.A.8
-
6
-
-
77952936173
-
Redox signaling, alkylation (carbonylation) of conserved cysteines inactivates class i histone deacetylases 1, 2, and 3 and antagonizes their transcriptional repressor function
-
20385560 10.1074/jbc.M109.089250 1:CAS:528:DC%2BC3cXmslSnurs%3D
-
K Doyle FA Fitzpatrick 2010 Redox signaling, alkylation (carbonylation) of conserved cysteines inactivates class I histone deacetylases 1, 2, and 3 and antagonizes their transcriptional repressor function J Biol Chem 285 17417 17424 20385560 10.1074/jbc.M109.089250 1:CAS:528:DC%2BC3cXmslSnurs%3D
-
(2010)
J Biol Chem
, vol.285
, pp. 17417-17424
-
-
Doyle, K.1
Fitzpatrick, F.A.2
-
7
-
-
67349201377
-
Targeting tumor angiogenesis with histone deacetylase inhibitors
-
19111391 10.1016/j.canlet.2008.11.012 1:CAS:528:DC%2BD1MXmsF2jt74%3D
-
L Ellis H Hammers R Pili 2009 Targeting tumor angiogenesis with histone deacetylase inhibitors Cancer Lett 280 145 153 19111391 10.1016/j.canlet.2008. 11.012 1:CAS:528:DC%2BD1MXmsF2jt74%3D
-
(2009)
Cancer Lett
, vol.280
, pp. 145-153
-
-
Ellis, L.1
Hammers, H.2
Pili, R.3
-
8
-
-
45849123896
-
A phase i and pharmacokinetic study of selenomethionine in combination with a fixed dose of irinotecan in solid tumors
-
17989978 10.1007/s00280-007-0631-4 1:CAS:528:DC%2BD1cXnt1Cjsro%3D
-
MG Fakih L Pendyala W Brady PF Smith ME Ross PJ Creaven V Badmaev JD Prey YM Rustum 2008 A phase I and pharmacokinetic study of selenomethionine in combination with a fixed dose of irinotecan in solid tumors Cancer Chemother Pharmacol 62 499 508 17989978 10.1007/s00280-007-0631-4 1:CAS:528: DC%2BD1cXnt1Cjsro%3D
-
(2008)
Cancer Chemother Pharmacol
, vol.62
, pp. 499-508
-
-
Fakih, M.G.1
Pendyala, L.2
Brady, W.3
Smith, P.F.4
Ross, M.E.5
Creaven, P.J.6
Badmaev, V.7
Prey, J.D.8
Rustum, Y.M.9
-
9
-
-
79251613742
-
HPLC with APEX-Q nebulisation ICP-MS and ESI MS/MS to compare selenium uptake and speciation in non-malignant cells and B cell lymphoma lines
-
21140135 10.1007/s00216-010-4474-1
-
H Goenaga-Infante S Kassam E Stokes C Hopley SP Joel 2010 HPLC with APEX-Q nebulisation ICP-MS and ESI MS/MS to compare selenium uptake and speciation in non-malignant cells and B cell lymphoma lines Anal Bioanal Chem 399 1789 1797 21140135 10.1007/s00216-010-4474-1
-
(2010)
Anal Bioanal Chem
, vol.399
, pp. 1789-1797
-
-
Goenaga-Infante, H.1
Kassam, S.2
Stokes, E.3
Hopley, C.4
Joel, S.P.5
-
10
-
-
34547479398
-
Investigation of the selenium species distribution in a human B-cell lymphoma line by HPLC- and GC-ICP-MS in combination with HPLC-ESIMS/MS and GC-TOFMS after incubation with methylseleninic acid
-
10.1039/b708620b 1:CAS:528:DC%2BD2sXotVantLk%3D
-
H Goenaga Infante S Joel E Warburton C Hopley R Hearn S Jüliger 2007 Investigation of the selenium species distribution in a human B-cell lymphoma line by HPLC- and GC-ICP-MS in combination with HPLC-ESIMS/MS and GC-TOFMS after incubation with methylseleninic acid J Anal At Spectrom 22 888 896 10.1039/b708620b 1:CAS:528:DC%2BD2sXotVantLk%3D
-
(2007)
J Anal at Spectrom
, vol.22
, pp. 888-896
-
-
Goenaga Infante, H.1
Joel, S.2
Warburton, E.3
Hopley, C.4
Hearn, R.5
Jüliger, S.6
-
11
-
-
58049197840
-
Locally generated methylseleninic acid induces specific inactivation of protein kinase C isoenzymes: Relevance to selenium-induced apoptosis in prostate cancer cells
-
18922790 10.1074/jbc.M807007200 1:CAS:528:DC%2BD1cXhsVGqtrjM
-
U Gundimeda JE Schiffman D Chhabra J Wong A Wu R Gopalakrishna 2008 Locally generated methylseleninic acid induces specific inactivation of protein kinase C isoenzymes: relevance to selenium-induced apoptosis in prostate cancer cells J Biol Chem 283 34519 34531 18922790 10.1074/jbc.M807007200 1:CAS:528:DC%2BD1cXhsVGqtrjM
-
(2008)
J Biol Chem
, vol.283
, pp. 34519-34531
-
-
Gundimeda, U.1
Schiffman, J.E.2
Chhabra, D.3
Wong, J.4
Wu, A.5
Gopalakrishna, R.6
-
12
-
-
79954629764
-
Chemical speciation influences comparative activity of selenium-enriched garlic and yeast in mammary cancer prevention
-
10995380 10.1021/jf000932m 1:CAS:528:DC%2BD3cXlt1entrw%3D
-
C Ip M Birringer E Block M Kotrebai JF Tyson PC Uden DJ Lisk 2000 Chemical speciation influences comparative activity of selenium-enriched garlic and yeast in mammary cancer prevention J Agric Food Chem 48 4452 10995380 10.1021/jf000932m 1:CAS:528:DC%2BD3cXlt1entrw%3D
-
(2000)
J Agric Food Chem
, vol.48
, pp. 4452
-
-
Ip, C.1
Birringer, M.2
Block, E.3
Kotrebai, M.4
Tyson, J.F.5
Uden, P.C.6
Lisk, D.J.7
-
13
-
-
0034214376
-
In vitro and in vivo studies of methylseleninic acid: Evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention
-
10850432 1:CAS:528:DC%2BD3cXjvFOlsbY%3D
-
C Ip HJ Thompson Z Zhu HE Ganther 2000 In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention Cancer Res 60 2882 2886 10850432 1:CAS:528:DC%2BD3cXjvFOlsbY%3D
-
(2000)
Cancer Res
, vol.60
, pp. 2882-2886
-
-
Ip, C.1
Thompson, H.J.2
Zhu, Z.3
Ganther, H.E.4
-
14
-
-
36349019345
-
Chemosensitization of B-cell lymphomas by methylseleninic acid involves nuclear factor-kappaB inhibition and the rapid generation of other selenium species
-
18006844 10.1158/0008-5472.CAN-07-0519
-
S Juliger H Goenaga-Infante TA Lister J Fitzgibbon SP Joel 2007 Chemosensitization of B-cell lymphomas by methylseleninic acid involves nuclear factor-kappaB inhibition and the rapid generation of other selenium species Cancer Res 67 10984 10992 18006844 10.1158/0008-5472.CAN-07-0519
-
(2007)
Cancer Res
, vol.67
, pp. 10984-10992
-
-
Juliger, S.1
Goenaga-Infante, H.2
Lister, T.A.3
Fitzgibbon, J.4
Joel, S.P.5
-
15
-
-
37849019672
-
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
-
17868033 10.1042/BJ20070779 1:CAS:528:DC%2BD1cXhtlSru7o%3D
-
N Khan M Jeffers S Kumar C Hackett F Boldog N Khramtsov X Qian E Mills SC Berghs N Carey PW Finn LS Collins A Tumber JW Ritchie PB Jensen HS Lichenstein M Sehested 2008 Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors Biochem J 409 581 589 17868033 10.1042/BJ20070779 1:CAS:528:DC%2BD1cXhtlSru7o%3D
-
(2008)
Biochem J
, vol.409
, pp. 581-589
-
-
Khan, N.1
Jeffers, M.2
Kumar, S.3
Hackett, C.4
Boldog, F.5
Khramtsov, N.6
Qian, X.7
Mills, E.8
Berghs, S.C.9
Carey, N.10
Finn, P.W.11
Collins, L.S.12
Tumber, A.13
Ritchie, J.W.14
Jensen, P.B.15
Lichenstein, H.S.16
Sehested, M.17
-
17
-
-
33646178191
-
The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours
-
16469755 10.1093/annonc/mdl004 1:STN:280:DC%2BD283jtVKlsQ%3D%3D
-
K Last L Maharaj J Perry S Strauss J Fitzgibbon TA Lister S Joel 2006 The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours Ann Oncol 17 773 779 16469755 10.1093/annonc/mdl004 1:STN:280:DC%2BD283jtVKlsQ%3D%3D
-
(2006)
Ann Oncol
, vol.17
, pp. 773-779
-
-
Last, K.1
Maharaj, L.2
Perry, J.3
Strauss, S.4
Fitzgibbon, J.5
Lister, T.A.6
Joel, S.7
-
18
-
-
0038488104
-
Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin's lymphoma
-
12805335 10.1200/JCO.2003.06.145
-
KW Last V Cornelius T Delves C Sieniawska J Fitzgibbon A Norton J Amess A Wilson AZ Rohatiner TA Lister 2003 Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin's lymphoma J Clin Oncol 21 2335 2341 12805335 10.1200/JCO.2003.06. 145
-
(2003)
J Clin Oncol
, vol.21
, pp. 2335-2341
-
-
Last, K.W.1
Cornelius, V.2
Delves, T.3
Sieniawska, C.4
Fitzgibbon, J.5
Norton, A.6
Amess, J.7
Wilson, A.8
Rohatiner, A.Z.9
Lister, T.A.10
-
19
-
-
69249166677
-
Alpha-keto acid metabolites of naturally occurring organoselenium compounds as inhibitors of histone deacetylase in human prostate cancer cells
-
10.1158/1940-6207.CAPR-09-0047 1:CAS:528:DC%2BC3cXptFKns74%3D
-
JI Lee H Nian AJ Cooper R Sinha J Dai WH Bisson RH Dashwood JT Pinto 2009 Alpha-keto acid metabolites of naturally occurring organoselenium compounds as inhibitors of histone deacetylase in human prostate cancer cells Cancer Prev Res (Phila) 2 683 693 10.1158/1940-6207.CAPR-09-0047 1:CAS:528:DC%2BC3cXptFKns74%3D
-
(2009)
Cancer Prev Res (Phila)
, vol.2
, pp. 683-693
-
-
Lee, J.I.1
Nian, H.2
Cooper, A.J.3
Sinha, R.4
Dai, J.5
Bisson, W.H.6
Dashwood, R.H.7
Pinto, J.T.8
-
20
-
-
47249097092
-
Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite
-
18310093 10.1093/carcin/bgn007 1:CAS:528:DC%2BD1cXot1WntrY%3D
-
GX Li HJ Lee Z Wang H Hu JD Liao JC Watts GF Combs Jr. J Lu 2008 Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite Carcinogenesis 29 1005 1012 18310093 10.1093/carcin/bgn007 1:CAS:528:DC%2BD1cXot1WntrY%3D
-
(2008)
Carcinogenesis
, vol.29
, pp. 1005-1012
-
-
Li, G.X.1
Lee, H.J.2
Wang, Z.3
Hu, H.4
Liao, J.D.5
Watts, J.C.6
Combs Jr., G.F.7
Lu, J.8
-
21
-
-
58149383852
-
Effect of selenium and vitamin e on risk of prostate cancer and other cancers: The selenium and vitamin e cancer prevention trial (SELECT)
-
19066370 10.1001/jama.2008.864 1:CAS:528:DC%2BD1MXntFKmsw%3D%3D
-
SM Lippman EA Klein PJ Goodman MS Lucia IM Thompson LG Ford HL Parnes LM Minasian JM Gaziano JA Hartline JK Parsons JD Bearden III ED Crawford GE Goodman J Claudio E Winquist ED Cook DD Karp P Walther MM Lieber AR Kristal AK Darke KB Arnold PA Ganz RM Santella D Albanes PR Taylor JL Probstfield TJ Jagpal JJ Crowley FL Meyskens Jr. LH Baker CA Coltman Jr. 2009 Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E cancer prevention trial (SELECT) JAMA 301 39 51 19066370 10.1001/jama.2008. 864 1:CAS:528:DC%2BD1MXntFKmsw%3D%3D
-
(2009)
JAMA
, vol.301
, pp. 39-51
-
-
Lippman, S.M.1
Klein, E.A.2
Goodman, P.J.3
Lucia, M.S.4
Thompson, I.M.5
Ford, L.G.6
Parnes, H.L.7
Minasian, L.M.8
Gaziano, J.M.9
Hartline, J.A.10
Parsons, J.K.11
Bearden Iii, J.D.12
Crawford, E.D.13
Goodman, G.E.14
Claudio, J.15
Winquist, E.16
Cook, E.D.17
Karp, D.D.18
Walther, P.19
Lieber, M.M.20
Kristal, A.R.21
Darke, A.K.22
Arnold, K.B.23
Ganz, P.A.24
Santella, R.M.25
Albanes, D.26
Taylor, P.R.27
Probstfield, J.L.28
Jagpal, T.J.29
Crowley, J.J.30
Meyskens Jr., F.L.31
Baker, L.H.32
Coltman Jr., C.A.33
more..
-
22
-
-
78649905409
-
Histone deacetylase inhibitors: A chemical genetics approach to understanding cellular functions
-
Marks PA (2010) Histone deacetylase inhibitors: a chemical genetics approach to understanding cellular functions. Biochim Biophys Acta 1799(10-12):717-725
-
(2010)
Biochim Biophys Acta
, vol.1799
, Issue.10-12
, pp. 717-725
-
-
Marks, P.A.1
-
23
-
-
69449083759
-
Alpha-keto acid metabolites of organoselenium compounds inhibit histone deacetylase activity in human colon cancer cells
-
19528666 10.1093/carcin/bgp147 1:CAS:528:DC%2BD1MXpsVakt7s%3D
-
H Nian WH Bisson WM Dashwood JT Pinto RH Dashwood 2009 Alpha-keto acid metabolites of organoselenium compounds inhibit histone deacetylase activity in human colon cancer cells Carcinogenesis 30 1416 1423 19528666 10.1093/carcin/bgp147 1:CAS:528:DC%2BD1MXpsVakt7s%3D
-
(2009)
Carcinogenesis
, vol.30
, pp. 1416-1423
-
-
Nian, H.1
Bisson, W.H.2
Dashwood, W.M.3
Pinto, J.T.4
Dashwood, R.H.5
-
24
-
-
31544479307
-
Cystathionine gamma-lyase contributes to selenomethionine detoxification and cytosolic glutathione peroxidase biosynthesis in mouse liver
-
16444005 10.1385/BTER:109:2:155 1:CAS:528:DC%2BD28XhtVequr8%3D
-
T Okuno H Ueno K Nakamuro 2006 Cystathionine gamma-lyase contributes to selenomethionine detoxification and cytosolic glutathione peroxidase biosynthesis in mouse liver Biol Trace Elem Res 109 155 171 16444005 10.1385/BTER:109:2:155 1:CAS:528:DC%2BD28XhtVequr8%3D
-
(2006)
Biol Trace Elem Res
, vol.109
, pp. 155-171
-
-
Okuno, T.1
Ueno, H.2
Nakamuro, K.3
-
25
-
-
33749006252
-
Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha
-
16951198 10.1158/0008-5472.CAN-05-4598 1:CAS:528:DC%2BD28XovF2htrw%3D
-
DZ Qian SK Kachhap SJ Collis HM Verheul MA Carducci P Atadja R Pili 2006 Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha Cancer Res 66 8814 8821 16951198 10.1158/0008-5472.CAN-05-4598 1:CAS:528:DC%2BD28XovF2htrw%3D
-
(2006)
Cancer Res
, vol.66
, pp. 8814-8821
-
-
Qian, D.Z.1
Kachhap, S.K.2
Collis, S.J.3
Verheul, H.M.4
Carducci, M.A.5
Atadja, P.6
Pili, R.7
-
26
-
-
28244462778
-
Selenium in cancer prevention: A review of the evidence and mechanism of action
-
16313696 10.1079/PNS2005467 1:CAS:528:DC%2BD28Xhs1Gisg%3D%3D
-
MP Rayman 2005 Selenium in cancer prevention: a review of the evidence and mechanism of action Proc Nutr Soc 64 527 542 16313696 10.1079/PNS2005467 1:CAS:528:DC%2BD28Xhs1Gisg%3D%3D
-
(2005)
Proc Nutr Soc
, vol.64
, pp. 527-542
-
-
Rayman, M.P.1
-
27
-
-
52949085127
-
Food-chain selenium and human health: Spotlight on speciation
-
18346307 1:CAS:528:DC%2BD1cXptF2gsb0%3D
-
MP Rayman HG Infante M Sargent 2008 Food-chain selenium and human health: spotlight on speciation Br J Nutr 100 238 253 18346307 1:CAS:528: DC%2BD1cXptF2gsb0%3D
-
(2008)
Br J Nutr
, vol.100
, pp. 238-253
-
-
Rayman, M.P.1
Infante, H.G.2
Sargent, M.3
|